Knee osteoarthritis: Long-term GLP-1RA therapy is disease-modifying

被引：0
|
作者：
Di Lellis, Maddalena Angela
机构：
来源：
AKTUELLE RHEUMATOLOGIE | 2024年 / 49卷 / 01期
关键词：
D O I：
10.1055/a-2183-6149
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Eine Gewichtsreduktion gilt als eine der ersten Ma ss nahmen bei Kniearthrose (KOA). Jungste Erkenntnisse deuten darauf hin, dass bei Diabetes mellitus Typ 2 empfohlene Glucagonlike-Peptid-1-Rezeptor-Agonisten (GLP-1RAs), die eine Gewichtsreduktion bewirken, eine geringe Verbesserung der von den Patienten berichteten Kurzzeit-Ergebnisse bewirken. Zhu et al. untersuchten, ob KOA-Patienten von einer GLP-1RA-Therapie profitieren konnen.
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [1] Comparative effectiveness of long-term users of disease-modifying therapy
    Salter, A.
    Tang, Y.
    Hornung, L.
    Kolodny, S.
    Hurtukova, D.
    Glenski, S.
    Cofield, S.
    Zhang, X.
    Cutter, G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 309 - 310
  • [2] Long-term efficiency of the disease-modifying treatment
    Debouverie, M.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S47 - S47
  • [3] Is there a disease-modifying effect of long-term cyclic iloprost therapy in systemic sclerosis?
    Airo, P.
    Scarsi, M.
    Danieli, E.
    Rossi, M.
    Grotto, A.
    Zambruni, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 197 - 197
  • [4] LONG-TERM MANAGEMENT OF RHEUMATOID-ARTHRITIS USING DISEASE-MODIFYING THERAPY
    KRAUSE, A
    GOEBEL, KM
    [J]. INNERE MEDIZIN, 1986, 13 (05) : 187 - 196
  • [5] Assessing long-term effects of disease-modifying drugs
    Kieseier, Bernd C.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 6) : 23 - 30
  • [6] Assessing long-term effects of disease-modifying drugs
    Bernd C. Kieseier
    [J]. Journal of Neurology, 2006, 253 : vi23 - vi30
  • [7] Neuromodulation as a Potential Disease-Modifying Therapy for Osteoarthritis
    Cruz, Carlos J.
    Dewberry, L. Savannah
    Otto, Kevin J.
    Allen, Kyle D.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2023, 25 (01) : 1 - 11
  • [8] Neuromodulation as a Potential Disease-Modifying Therapy for Osteoarthritis
    Carlos J. Cruz
    L. Savannah Dewberry
    Kevin J. Otto
    Kyle D. Allen
    [J]. Current Rheumatology Reports, 2023, 25 : 1 - 11
  • [9] CLINICAL RESEARCH IN OSTEOARTHRITIS - DESIGN AND RESULTS OF SHORT-TERM AND LONG-TERM TRIALS WITH DISEASE-MODIFYING DRUGS
    ROVATI, LC
    [J]. INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS, 1992, 14 (05): : 243 - 251
  • [10] Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis
    Stuart, WH
    Cohan, S
    Richert, JR
    Achiron, A
    [J]. NEUROLOGY, 2004, 63 (11) : S19 - S27
12345